This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Henttu, P. Articles by Vihko, P. Search for Related Content PubMed PubMed Citation Articles by Henttu, P. Articles by Vihko, P.

Growth Factor Regulation of Gene Expression in the Human Prostatic Carcinoma Cell Line LNCaP¹

Biocenter and Department of Clinical Chemistry, University of Oulu, Kajaanintie 50, SF-90220 Oulu, Finland

In order to characterize the effects of growth factors on the regulation of expression of the genes coding for prostatic differentiation markers, prostatic acid phosphatase and prostate-specific antigen, we studied changes occurring in the biosynthesis of these enzymes in LNCaP prostatic cancer cells treated with growth factors. Epidermal growth factor was found to reduce the secretion of prostatic acid phosphatase and prostatespecific antigen by the cells, as the result of lowered steady-state levels of the corresponding messenger RNAs (mRNAs). In addition, epidermal growth factor (EGF) interfered with the androgen regulation of these genes. EGF evoked these changes in a concentration- and time-dependent fashion, in both the presence and absence of serum and most likely through interactions with the epidermal growth factor receptor, inasmuch as similar effects were achieved by treating the cells with transforming growth factor . The regulation of the human glandular kallikrein 1 gene was quite similar to the regulation of the prostate-specific antigen gene. In addition to the expression of the genes coding for prostatic secretory proteins, the amount of the human androgen receptor mRNA was down-regulated by EGF. This reduction was more pronounced than the autologous down-regulation of human androgen receptor (hAR) mRNA by androgen and could be maintained for at least 5 days. In the presence of androgen, some of the effects of EGF and transforming growth factor on the levels of androgen-regulated mRNAs may be due to down-regulation of the expression of the hAR gene. Transforming growth factor ß₁, which blocked the growth induction of LNCaP cells by EGF, increased the level of prostatic acid phosphatase and hAR mRNAs, but when given to the cells together with EGF its up-regulatory effect could not be discerned. In summary, regulation of the prostatic acid phosphatase and prostate-specific antigen genes is a complex matter, inasmuch as androgens and growth factors regulate the levels of the mRNAs originating from them. Furthermore, the interactions between the androgen-regulatory system and the growth factor-regulatory systems are likely to be at multiple levels in prostatic cells, as suggested by the modulation of the hAR gene expression by these growth factors.

¹ This research was supported in part by the Sigrid Jusélius Foundation, the Finnish Cancer Foundation, and the Research Council for Medicine of the Academy of Finland. The Department of Clinical Chemistry, University of Oulu, is a WHO Collaborating Centre for Research in Human Reproduction supported by the Ministry of Education, the Ministry of Health and Social Affairs, and the Ministry of Foreign Affairs, Finland.

² To whom requests for reprints should be addressed.

Received 6/30/92. Accepted 12/15/92.

This article has been cited by other articles:

				H. Cheng, R. Snoek, F. Ghaidi, M. E. Cox, and P. S. Rennie Short Hairpin RNA Knockdown of the Androgen Receptor Attenuates Ligand-Independent Activation and Delays Tumor Progression Cancer Res., November 1, 2006; 66(21): 10613 - 10620. [Abstract] [Full Text] [PDF]

				Z Culig, H Steiner, G Bartsch, and A Hobisch Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours Endocr. Relat. Cancer, June 1, 2005; 12(2): 229 - 244. [Abstract] [Full Text] [PDF]

				C. A. Heinlein and C. Chang Androgen Receptor in Prostate Cancer Endocr. Rev., April 1, 2004; 25(2): 276 - 308. [Abstract] [Full Text] [PDF]

				T. Ueda, N. Bruchovsky, and M. D. Sadar Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways J. Biol. Chem., February 22, 2002; 277(9): 7076 - 7085. [Abstract] [Full Text] [PDF]

				M. A. Sortino, F. Condorelli, C. Vancheri, A. Chiarenza, R. Bernardini, U. Consoli, and P. L. Canonico Mitogenic Effect of Nerve Growth Factor (NGF) in LNCaP Prostate Adenocarcinoma Cells: Role of the High- and Low-Affinity NGF Receptors Mol. Endocrinol., January 1, 2000; 14(1): 124 - 136. [Abstract] [Full Text]

				M. J. Gerdes, T. D. Dang, M. Larsen, and D. R. Rowley Transforming Growth Factor-{beta}1 Induces Nuclear to Cytoplasmic Distribution of Androgen Receptor and Inhibits Androgen Response in Prostate Smooth Muscle Cells Endocrinology, August 1, 1998; 139(8): 3569 - 3577. [Abstract] [Full Text] [PDF]

				C. Guillemette, E. Levesque, M. Beaulieu, D. Turgeon, D. W. Hum, and A. Belanger Differential Regulation of Two Uridine Diphospho-Glucuronosyltransferases, UGT2B15 and UGT2B17, in Human Prostate LNCaP Cells Endocrinology, July 1, 1997; 138(7): 2998 - 3005. [Abstract] [Full Text] [PDF]

				A. M. Nakhla, N. A. Romas, and W. Rosner Estradiol Activates the Prostate Androgen Receptor and Prostate-specific Antigen Secretion through the Intermediacy of Sex Hormone-binding Globulin J. Biol. Chem., March 14, 1997; 272(11): 6838 - 6841. [Abstract] [Full Text] [PDF]

				A. Herrala, R. Kurkela, K. Porvari, R. Isomaki, P. Henttu, and P. Vihko Human prostate-specific glandular kallikrein is expressed as an active and an inactive protein Clin. Chem., February 1, 1997; 43(2): 279 - 284. [Abstract] [Full Text] [PDF]

				M. E. Grossmann and D. J. Tindall The Androgen Receptor Is Transcriptionally Suppressed by Proteins That Bind Single-stranded DNA J. Biol. Chem., May 5, 1995; 270(18): 10968 - 10975. [Abstract] [Full Text] [PDF]